Washington Capital Management Inc Cooper Companies, Inc. Transaction History

Washington Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Sep 18, 2023	SELL	$248.67 - $334.17 $45,257 - $60,818	-182 Reduced 16.55%	918 $303,000
Q3 2021 Sep 18, 2023	BUY	$396.76 - $455.92 $436,436 - $501,512	1,100 New	1,100 $454,000
Q1 2019 May 06, 2019	SELL	$246.18 - $297.25 $184,635 - $222,937	-750 Reduced 34.88%	1,400 $415,000
Q2 2018 Aug 06, 2018	BUY	$217.98 - $237.23 $65,394 - $71,169	300 Added 16.22%	2,150 $506,000
Q1 2018 May 08, 2018	BUY	$218.74 - $251.43 $131,244 - $150,858	600 Added 48.0%	1,850 $423,000
Q4 2017 Jan 25, 2018	BUY	$217.88 - $244.43 $272,350 - $305,537	1,250	1,250 $272,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Washington Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Washington Capital Management Inc with notifications on news.